159 related articles for article (PubMed ID: 18337456)
21. Delayed cell cycle progression in selenoprotein W-depleted cells is regulated by a mitogen-activated protein kinase kinase 4-p38/c-Jun NH2-terminal kinase-p53 pathway.
Hawkes WC; Alkan Z
J Biol Chem; 2012 Aug; 287(33):27371-9. PubMed ID: 22730327
[TBL] [Abstract][Full Text] [Related]
22. Distinct signaling properties of mitogen-activated protein kinase kinases 4 (MKK4) and 7 (MKK7) in embryonic stem cell (ESC) differentiation.
Wang J; Chen L; Ko CI; Zhang L; Puga A; Xia Y
J Biol Chem; 2012 Jan; 287(4):2787-97. PubMed ID: 22130668
[TBL] [Abstract][Full Text] [Related]
23. Increased MKK4 abundance with replicative senescence is linked to the joint reduction of multiple microRNAs.
Marasa BS; Srikantan S; Masuda K; Abdelmohsen K; Kuwano Y; Yang X; Martindale JL; Rinker-Schaeffer CW; Gorospe M
Sci Signal; 2009 Oct; 2(94):ra69. PubMed ID: 19861690
[TBL] [Abstract][Full Text] [Related]
24. The mitogen-activated protein kinase kinase 4 has a pro-oncogenic role in skin cancer.
Finegan KG; Tournier C
Cancer Res; 2010 Jul; 70(14):5797-806. PubMed ID: 20610622
[TBL] [Abstract][Full Text] [Related]
25. Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity.
Yang D; Tournier C; Wysk M; Lu HT; Xu J; Davis RJ; Flavell RA
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3004-9. PubMed ID: 9096336
[TBL] [Abstract][Full Text] [Related]
26. MKK4 acts as a potential tumor suppressor in ovarian cancer.
Yeasmin S; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Katagiri A; Iida K; Nakayama N; Miyazaki K
Tumour Biol; 2011 Aug; 32(4):661-70. PubMed ID: 21487811
[TBL] [Abstract][Full Text] [Related]
27. Mitogen-activated protein kinase kinase 4 (MKK4).
Cuenda A
Int J Biochem Cell Biol; 2000 Jun; 32(6):581-7. PubMed ID: 10785355
[TBL] [Abstract][Full Text] [Related]
28. Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancer.
Ishikawa M; Nakayama K; Rahman MT; Rahman M; Katagiri A; Iida K; Miyazaki K
Oncology; 2010; 79(3-4):238-46. PubMed ID: 21372598
[TBL] [Abstract][Full Text] [Related]
29. Specific amino acid deficiency alters the expression of genes in human melanoma and other tumor cell lines.
Meadows GG; Zhang H; Ge X
J Nutr; 2001 Nov; 131(11 Suppl):3047S-50S. PubMed ID: 11694646
[TBL] [Abstract][Full Text] [Related]
30. Activation of p38 mitogen-activated protein kinase and c-Jun NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways.
Iordanov MS; Paranjape JM; Zhou A; Wong J; Williams BR; Meurs EF; Silverman RH; Magun BE
Mol Cell Biol; 2000 Jan; 20(2):617-27. PubMed ID: 10611240
[TBL] [Abstract][Full Text] [Related]
31. MKK4 activates non-canonical NFκB signaling by promoting NFκB2-p100 processing.
Kim JS; Kim EJ; Kim HS; Kurie JM; Ahn YH
Biochem Biophys Res Commun; 2017 Sep; 491(2):337-342. PubMed ID: 28733031
[TBL] [Abstract][Full Text] [Related]
32. Differential regulation of mitogen-activated protein kinase kinase 4 (MKK4) and 7 (MKK7) by signaling from G protein beta gamma subunit in human embryonal kidney 293 cells.
Yamauchi J; Kaziro Y; Itoh H
J Biol Chem; 1999 Jan; 274(4):1957-65. PubMed ID: 9890951
[TBL] [Abstract][Full Text] [Related]
33. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.
Teng DH; Perry WL; Hogan JK; Baumgard M; Bell R; Berry S; Davis T; Frank D; Frye C; Hattier T; Hu R; Jammulapati S; Janecki T; Leavitt A; Mitchell JT; Pero R; Sexton D; Schroeder M; Su PH; Swedlund B; Kyriakis JM; Avruch J; Bartel P; Wong AK; Tavtigian SV
Cancer Res; 1997 Oct; 57(19):4177-82. PubMed ID: 9331070
[TBL] [Abstract][Full Text] [Related]
34. Role of the functional MKK4 promoter variant (-1304T>G) in a decreased risk of prostate cancer: case-control study and meta-analysis.
Shao N; Wang Y; Lu K; Jiang WY; Li Q; Wang N; Feng NH; Hua LX
J Cancer Res Clin Oncol; 2012 Sep; 138(9):1531-9. PubMed ID: 22526163
[TBL] [Abstract][Full Text] [Related]
35. Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis.
Hammaker DR; Boyle DL; Chabaud-Riou M; Firestein GS
J Immunol; 2004 Feb; 172(3):1612-8. PubMed ID: 14734742
[TBL] [Abstract][Full Text] [Related]
36. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
Chuang SM; Wang IC; Yang JL
Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
[TBL] [Abstract][Full Text] [Related]
37. MKK4 and metastasis suppression: a marriage of signal transduction and metastasis research.
Robinson VL; Hickson JA; Vander Griend DJ; Dubauskas Z; Rinker-Schaeffer CW
Clin Exp Metastasis; 2003; 20(1):25-30. PubMed ID: 12650604
[TBL] [Abstract][Full Text] [Related]
38. Induction of cyclooxygenase-2 by the activated MEKK1 --> SEK1/MKK4 --> p38 mitogen-activated protein kinase pathway.
Guan Z; Buckman SY; Pentland AP; Templeton DJ; Morrison AR
J Biol Chem; 1998 May; 273(21):12901-8. PubMed ID: 9582321
[TBL] [Abstract][Full Text] [Related]
39. Thioredoxin Activates MKK4-NFκB Pathway in a Redox-dependent Manner to Control Manganese Superoxide Dismutase Gene Expression in Endothelial Cells.
Kundumani-Sridharan V; Subramani J; Das KC
J Biol Chem; 2015 Jul; 290(28):17505-19. PubMed ID: 26028649
[TBL] [Abstract][Full Text] [Related]
40. ROCK activity affects IL-1-induced signaling possibly through MKK4 and p38 MAPK in Caco-2 cells.
Banerjee S; McGee DW
In Vitro Cell Dev Biol Anim; 2016 Sep; 52(8):878-84. PubMed ID: 27173611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
